Dr. Wapnir Receives Smart Foundation Funding for Breast Cancer Research
January 13, 2025
Dr. Irene Wapnir has received funding from the Smart Foundation for her research project: “Early and Late Hormone-positive Ipsilateral Breast Tumor Recurrences’ Genomic Signatures.”
“Our study focuses on trying to characterize the types of tumors that recur locally after lumpectomy or breast conserving surgery,” said Wapnir. “Some of these recurrences appear decades later, so we wonder: are these new cancers that develop or cancer cells that remained dormant in the area and survived all the prior treatments?”
About half of these recurrences are highly-associated with the presence of metastasis in tissues and organs outside the breast. Genomic signatures have defined sub-groups of tumors with aggressive and less aggressive behaviors.
“One of the goals of our research is to correlate these signatures to early or late recurrences. In fact, we might use the findings to classify an in-breast recurrence as early or late,” said Wapnir.
Wapnir will be working closely with Dr. Colin Bergstrom, one of the fellows in the Breast Program who has worked with Dr. Jennifer Caswell and Dr. Christina Curtis on these genomic signatures.
Much of Wapnir’s national clinical trials work has been on studying the longterm outcomes of patient in NSABP trials who experienced locoregional recurrences. She was also chair of Chemotherapy as Adjuvant for Locally Recurrent breast cancer (CALOR) trial, which investigated the effectiveness of chemotherapy after local therapy for isolated locoregional recurrence.
Additionally, the Williams Foundation is continuing to support Dr. Wapnir’s project: Investigator Initiated Randomized Trial of Neoadjuvant partial breast radiation therapy for ductal carcinoma in situ (DCIS).
Media Contact
Bio
About Stanford Surgery
The Stanford University Department of Surgery is dedicated to inventing the future of surgical care through:
• pioneering cutting-edge research,
• developing the next generation of leaders, and
• healing through incomparable surgical skills and compassion.
To learn more, please visit surgery.stanford.edu
The Latest
– SurgeryINSIDE: PCSA2026
Two general surgery residents won awards at the Pacific Coast Surgical Association's 97th annual meeting this year in Oahu, Hawaii.
– SurgeryINSIDE: ASC2026
Stanford Surgery trainees from across several disciplines presented at the 21st annual Academic Surgical Congress held in Orlando, Florida last week.
– SurgeryExploring the Intersection of Surgery and Cancer Research with Dr. Dan Delitto
Dr. Dan Delitto is an assistant professor of surgery at Stanford University specializes in surgical oncology and holds a PhD in immunology. On this episode, Dr. Delitto reflects on his decision to pursue an MD-PhD pathway during residency and discusses the recent advancements in single-cell RNA sequencing technology that his lab has acquired. He explains the complex role of fibroblasts in cancer development, particularly in pancreatic ductal carcinoma, highlighting how these cells can both promote and hinder tumor growth.
– CAP ProfilesDr. Clifford Sheckter Promoted to Associate Professor
Clifford Sheckter, MD, MS, FACS has been promoted to Associate Professor effective March 1, 2026. Dr. Sheckter works in the Division of Plastic and Reconstructive Surgery.
– Abdominal TransplantationINSIDE ASTS 2026: Stanford Abdominal Transplantation Surgery Recap
The American Society of Transplant Surgeons (ASTS) Winter Symposium was held January 22–25, 2026 at the Sheraton Grand at Wild Horse Pass in Phoenix, Arizona. The symposium brings together leading experts from across the field to share emerging research, discuss innovations in transplant care, and highlight key developments shaping the future of transplantation. There were several contributions from Stanford.